Literature DB >> 2731976

Induction of tumor necrosis factor alpha by spherules of Coccidioides immitis.

D C Slagle1, R A Cox, U Kuruganti.   

Abstract

The cytokine tumor necrosis factor alpha (TNF-alpha) functions as an immunomodulatory protein and as a mediator of cachexia. We report that viable or Formalin-killed spherules of Coccidioides immitis induced the secretion of TNF-alpha by peritoneal-exudate cells from BALB/c mice. The identification of the cytokine as TNF-alpha was based on its lytic activity against the TNF-alpha-sensitive LS murine fibrosarcoma cell line but not the TNF-alpha-resistant LR cell line, its neutralization by rabbit anti-TNF-alpha, and its secretion by peritoneal cells having characteristics of macrophages. The induction of TNF-alpha was to spherules and not to contaminating lipopolysaccharide (endotoxin), as evidenced by the finding that polymyxin B, a reagent that blocks the TNF-alpha-inducing component of lipopolysaccharide, did not negate the production of TNF-alpha in response to spherules, whereas pretreatment of spherules with hyperimmune goat antiserum to spherulin neutralized the induction of TNF-alpha by these cells. The demonstration that C. immitis activates macrophages to secrete TNF-alpha in vitro is a new finding and warrants studies to determine whether this cytokine is produced during active coccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731976      PMCID: PMC313820          DOI: 10.1128/iai.57.7.1916-1921.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Elimination of macrophages with silica and asbestos.

Authors:  E Kagan; D P Hartmann
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

2.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

3.  Tumor necrosis factor induction by Sendai virus.

Authors:  D Aderka; H Holtmann; L Toker; T Hahn; D Wallach
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

4.  Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes.

Authors:  J Y Djeu; D K Blanchard; A L Richards; H Friedman
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

5.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

Authors:  J Taverne; J Tavernier; W Fiers; J H Playfair
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

7.  Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.

Authors:  E H De Titto; J R Catterall; J S Remington
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

8.  Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function.

Authors:  D K Blanchard; J Y Djeu; T W Klein; H Friedman; W E Stewart
Journal:  J Leukoc Biol       Date:  1988-05       Impact factor: 4.962

9.  Macrophage activation by monosaccharide precursors of Escherichia coli lipid A.

Authors:  M Nishijima; F Amano; Y Akamatsu; K Akagawa; T Tokunaga; C R Raetz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  Production of tumor necrosis factor during murine listeriosis.

Authors:  E A Havell
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

View more
  16 in total

Review 1.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 2.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

3.  Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.

Authors:  C Jiang; D M Magee; T N Quitugua; R A Cox
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

4.  Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1.

Authors:  Suganya Viriyakosol; Joshua Fierer; Gordon D Brown; Theo N Kirkland
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 5.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Effects of recombinant gamma interferon and tumor necrosis factor on in vitro interactions of human mononuclear phagocytes with Coccidioides immitis.

Authors:  L Beaman
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Production of tumor necrosis factor alpha, interleukin-1 alpha, and interleukin-6 during murine coccidioidomycosis.

Authors:  R A Cox; D M Magee
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 8.  Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.

Authors:  Jeannina A Smith; Carol A Kauffman
Journal:  Drugs       Date:  2009-07-30       Impact factor: 9.546

9.  Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

10.  Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice.

Authors:  B A Wu-Hsieh; G S Lee; M Franco; F M Hofman
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.